Home/Filings/4/0001623919-16-000098
4//SEC Filing

EndoChoice Holdings, Inc. 4

Accession 0001623919-16-000098

CIK 0001623919operating

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 10:21 AM ET

Size

11.9 KB

Accession

0001623919-16-000098

Insider Transaction Report

Form 4
Period: 2016-11-22
GILL DAVID N
See remarks.
Transactions
  • Disposition to Issuer

    Common stock, par value $0.001 per share

    2016-11-22$8.00/sh125,445$1,003,5600 total
  • Disposition to Issuer

    Common stock, par value $0.001 per share

    2016-11-22$8.00/sh38,585$308,6800 total(indirect: By Trust)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2016-11-2232,2300 total
    Exercise: $5.31Exp: 2026-03-29Common stock, par value $0.001 per share (32,230 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2016-11-2253,8250 total
    Exercise: $16.01Exp: 2025-08-14Common stock, par value $0.001 per share (53,825 underlying)
Footnotes (5)
  • [F1]From April 1, 2016 through and including November 14, 2016, the reporting person transferred directly held shares to his indirectly held joint living trust, which resulted in a decrease in direct shares held and an increase in indirect shares held.
  • [F2]Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer.
  • [F3]This option was cancelled pursuant to the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $8.00 per share.
  • [F4]Issuer's outstanding stock options, if not yet vested, became fully vested pursuant to the terms and conditions of the Merger.
  • [F5]This option was cancelled pursuant to the Merger. Since the exercise price of this option exceeded the merger consideration of $8.00 per common shares, no value was received by the reporting person.

Issuer

EndoChoice Holdings, Inc.

CIK 0001623919

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001623919

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 10:21 AM ET
Size
11.9 KB